Company intelligence / Profile preview

Epres Technologies

California, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Epres commercializes patented bond-repair and molecular repair technology for hair and nail health (restoring keratin, strengthening structure), demonstrating efficacy in both professional and home settings; continuous repair claimed post-application, with visible improvements in hair strength, softness, and nail integrity

Therapeutic areas: Dermatology
Modalities: Bond repair technologyBiodiffusion™ TechnologyMolecular repair of keratin-based structures
Industry: Non-Drug Biotech

Partnerships

GoopAmazonprofessional salonsglobal beauty distribution networks

Beyond the preview

Go deeper on Epres Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epres Technologies.

Explore the full profile